InflaRx (IFRX) Current Leases (2019 - 2025)
InflaRx's (IFRX) quarterly Current Leases came in at $299092.8 in Q4 2025, down 31.06% year-on-year from $433871.1 in Q4 2024, and down 31.06% quarter-over-quarter from $433871.1 in Q4 2024.
InflaRx (IFRX) Current Leases (2019 - 2025) Analysis & Trends
InflaRx has disclosed Current Leases across 7 years of filings, most recently posting $299092.8 for Q4 2025.
- Current Leases for Q4 2025 came in at $299092.8, down 31.06% year-over-year; the trailing twelve-month figure through Dec 2025 was $299092.8 (down 31.06% YoY), and the FY2025 annual result was $299092.8, down 31.06% from the prior year.
- Current Leases came in at $299092.8 for Q4 2025 at InflaRx, down from $433871.1 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $429.1 billion in Q3 2021 to a low of $299092.8 in Q4 2025.
- The 5-year median for Current Leases is $410822.2 (2021), against an average of $71.5 billion.
- Across the five-year window, Current Leases soared 71700.39% in 2021 and plunged 31.06% in 2025, its largest moves.
- InflaRx's Current Leases stood at $418889.0 in 2021, then dropped by 10.03% to $376854.9 in 2022, then increased by 6.87% to $402755.5 in 2023, then advanced by 7.73% to $433871.1 in 2024, then slumped by 31.06% to $299092.8 in 2025.
- The last three Current Leases figures came in at $299092.8 (Q4 2025), $433871.1 (Q4 2024), and $402755.5 (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 42,980.09 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | InflaRx | 764.68 Mn | 764.68 Mn | 10,877.40 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 299,092.83 |
| Dec 31, 2024 | 433,871.10 |
| Dec 31, 2023 | 402,755.51 |
| Dec 31, 2022 | 376,854.89 |
| Dec 31, 2021 | 418,888.99 |
| Sep 30, 2021 | 429.11 Bn |
| Dec 31, 2020 | 403,609.19 |
| Sep 30, 2020 | 597.65 Mn |
| Jun 30, 2020 | 577.20 Mn |
| Mar 31, 2020 | 565.33 Mn |
| Dec 31, 2019 | 570,271.85 |